RepliCel Life Sciences Inc (TSXV:RP)
RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.
Pfizer Upjohn formally opened its new global headquarters in Shanghai, the first international headquarters of a multinational drug company located in China. Pfizer Upjohn is Pfizer’s generic and off-patent drug unit. Upjohn manufactures and markets 20 of Pfizer’s post-patent protected and generic products. Last year, faced with losing patent protection on Lyrica, its anti-seizure drug, Pfizer reorganized into three units: Innovative Medicines (including biosimilars); a hospital business for anti-infectives and sterile injectables; and Pfizer Upjohn for off-patent branded and generic drugs for non-communicable diseases.
Source: China Biotoday
